AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
The Bears 'rushing attack has been efficient the last two weeks. Tina Nguyen chats with Darnell Wright about what's been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback